TREVENA, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 43 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-12-10: Reporting owner Yoder Robert T; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2018-12-06: Reporting owner Yoder Robert T; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-12-06: Reporting owner Demitrack Mark; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2018-12-06: Reporting owner Bourdow Carrie L.; Form 4; Security Employee Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-12-10 holding as of filing | Yoder Robert T Officer (Sr. VP, Chief Business Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.79 exercise price | 2018-12-10 | ||
| 2018-12-06 | Yoder Robert T Officer (Sr. VP, Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $0.65 exercise price | 2018-12-10 | |
| 2018-12-06 | Demitrack Mark Officer (Sr VP & Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $0.65 exercise price | 2018-12-07 | |
| 2018-12-06 | Bourdow Carrie L. Director, Officer (President and CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $0.65 exercise price | 2018-12-07 | |
| 2018-09-27 | Bourdow Carrie L. Director, Officer (President and CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +335,000 335,000 owned after | $2.25 exercise price | 2018-10-01 | |
| 2018-09-27 | Braunstein Scott Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $2.25 exercise price | 2018-10-01 | |
| 2018-08-31 | Hamill John P. Officer (VP Fin,Princ Fin&Acct Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +52,500 52,500 owned after | $1.80 exercise price | 2018-09-04 | |
| 2018-05-21 | Demitrack Mark Officer (Sr VP & Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.78 exercise price | 2018-05-23 | |
| 2018-05-16 | Nunn Jason Raleigh Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $1.84 exercise price | 2018-05-17 | |
| 2018-05-16 | Yanni Barbara Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $1.84 exercise price | 2018-05-17 | |
| 2018-05-16 | Phillips Anne M. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $1.84 exercise price | 2018-05-17 | |
| 2018-05-16 | Koppel Adam Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $1.84 exercise price | 2018-05-17 | |
| 2018-05-16 | DOUGHERTY MICHAEL R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $1.84 exercise price | 2018-05-17 | |
| 2018-05-16 | MOULDER LEON O JR Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $1.84 exercise price | 2018-05-17 | |
| 2018-05-16 | McHugh Julie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $1.84 exercise price | 2018-05-17 | |
| 2018-02-28 | Violin Jonathan Officer (SVP-Scientific Affairs & IR) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | Violin Jonathan Officer (SVP-Scientific Affairs & IR) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | Limongelli John M Officer (Sr. VP,General Counsel & CAO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,000 44,000 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | Limongelli John M Officer (Sr. VP,General Counsel & CAO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | Habib Yacoub Officer (SVP, Bus Dev & Corp Planning) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,000 44,000 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | Habib Yacoub Officer (SVP, Bus Dev & Corp Planning) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | Geoghegan David Officer (Sr. VP, Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | Geoghegan David Officer (Sr. VP, Operations) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | Cuca Roberto Officer (Sr. VP and CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,000 44,000 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | Cuca Roberto Officer (Sr. VP and CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | Bourdow Carrie L. Officer (EVP & COO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +124,000 124,000 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | Bourdow Carrie L. Officer (EVP & COO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +112,500 112,500 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | GOWEN MAXINE Director, Officer (President & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-28 | GOWEN MAXINE Director, Officer (President & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +252,500 252,500 owned after | $1.79 exercise price | 2018-03-02 | |
| 2018-02-08 holding as of filing | Violin Jonathan Officer (SVP-Scientific Affairs & IR) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $2.23 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Violin Jonathan Officer (SVP-Scientific Affairs & IR) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $7.40 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Violin Jonathan Officer (SVP-Scientific Affairs & IR) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $6.79 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Violin Jonathan Officer (SVP-Scientific Affairs & IR) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $8.82 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Violin Jonathan Officer (SVP-Scientific Affairs & IR) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $6.61 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Violin Jonathan Officer (SVP-Scientific Affairs & IR) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $4.13 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Violin Jonathan Officer (SVP-Scientific Affairs & IR) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $3.34 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Violin Jonathan Officer (SVP-Scientific Affairs & IR) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $2.27 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Geoghegan David Officer (Sr. VP, Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $10.35 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Geoghegan David Officer (Sr. VP, Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $8.82 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Geoghegan David Officer (Sr. VP, Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $6.61 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Geoghegan David Officer (Sr. VP, Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $4.13 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Geoghegan David Officer (Sr. VP, Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $3.38 exercise price | 2018-02-08 | ||
| 2018-02-08 holding as of filing | Geoghegan David Officer (Sr. VP, Operations) | 3 | Employee Stock Option (Right to Buy) Derivative · Direct | Holding | $2.37 exercise price | 2018-02-08 |